VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,174 | -3.6% | 10,228 | +47.0% | 0.00% | – |
| Q2 2023 | $45,833 | +6.0% | 6,957 | +9.3% | 0.00% | – |
| Q1 2023 | $43,221 | +35.1% | 6,367 | +43.6% | 0.00% | – |
| Q4 2022 | $32,000 | -31.9% | 4,435 | -7.7% | 0.00% | – |
| Q3 2022 | $47,000 | -21.7% | 4,805 | -13.2% | 0.00% | – |
| Q2 2022 | $60,000 | -3.2% | 5,535 | +3.0% | 0.00% | – |
| Q1 2022 | $62,000 | -20.5% | 5,373 | +8.7% | 0.00% | – |
| Q4 2021 | $78,000 | +5.4% | 4,944 | +13.1% | 0.00% | – |
| Q3 2021 | $74,000 | -20.4% | 4,372 | +0.7% | 0.00% | – |
| Q2 2021 | $93,000 | +60.3% | 4,342 | +13.7% | 0.00% | – |
| Q1 2021 | $58,000 | +31.8% | 3,819 | +13.9% | 0.00% | – |
| Q4 2020 | $44,000 | +51.7% | 3,352 | +23.0% | 0.00% | – |
| Q3 2020 | $29,000 | -32.6% | 2,726 | -27.0% | 0.00% | – |
| Q2 2020 | $43,000 | +53.6% | 3,732 | +43.0% | 0.00% | – |
| Q1 2020 | $28,000 | – | 2,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |